Cardiex Ltd Cash Flow Conversion Efficiency
Cardiex Ltd cash flow conversion efficiency. Based on the latest financial reports, Cardiex Ltd (CDX) has a cash flow conversion efficiency ratio of -0.452x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.99 Million ≈ $-2.11 Million USD) by net assets (AU$6.60 Million ≈ $4.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Cardiex Ltd (2005–2024)
Cash flow conversion efficiency of Cardiex Ltd from 2005 to 2024. This chart illustrates how Cardiex Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Cardiex Ltd (CDX) share price today for real-time trading data and today's change.
Cardiex Ltd Cash Flow Conversion Ratio Explained
Cardiex Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Cardiex Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cardiex Ltd ranked by their cash flow conversion efficiency. Also see Cardiex Ltd (CDX) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PT Jaya Bersama Indo Tbk
JK:DUCK
|
-0.035x |
|
Moment Group AB
ST:MOMENT
|
-0.613x |
|
Welcron Hantec Co.Ltd
KQ:076080
|
-0.066x |
|
AVOD Kurutulmus Gida ve Tarim Urunleri Sanayi Ticaret AS
IS:AVOD
|
0.117x |
|
Crown Lifters Limited
NSE:CROWN
|
0.022x |
|
Geratherm Medical AG
XETRA:GME
|
0.021x |
|
Peak Processing Limited
AU:PKP
|
0.576x |
|
Castle Peak Holdings Public Company Limited
BK:CPH
|
0.145x |
Annual Cash Flow Conversion Efficiency for Cardiex Ltd (2005–2024)
The table below shows the annual cash flow conversion efficiency of Cardiex Ltd from 2005 to 2024. Review Cardiex Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | AU$4.09 Million ≈ $2.89 Million |
AU$-7.72 Million ≈ $-5.46 Million |
-1.889x | -115.76% |
| 2023-06-30 | AU$-1.00 Million ≈ $-708.11K |
AU$-12.00 Million ≈ $-8.49 Million |
11.987x | +924.03% |
| 2022-06-30 | AU$6.61 Million ≈ $4.68 Million |
AU$-9.62 Million ≈ $-6.80 Million |
-1.455x | -189.65% |
| 2021-06-30 | AU$7.91 Million ≈ $5.60 Million |
AU$-3.97 Million ≈ $-2.81 Million |
-0.502x | -73.83% |
| 2020-06-30 | AU$5.88 Million ≈ $4.16 Million |
AU$-1.70 Million ≈ $-1.20 Million |
-0.289x | +12.33% |
| 2019-06-30 | AU$6.95 Million ≈ $4.92 Million |
AU$-2.29 Million ≈ $-1.62 Million |
-0.330x | -630.02% |
| 2018-06-30 | AU$4.60 Million ≈ $3.25 Million |
AU$-207.49K ≈ $-146.82K |
-0.045x | +98.04% |
| 2017-06-30 | AU$1.33 Million ≈ $939.99K |
AU$-3.07 Million ≈ $-2.17 Million |
-2.308x | -47.31% |
| 2016-06-30 | AU$3.14 Million ≈ $2.22 Million |
AU$-4.92 Million ≈ $-3.48 Million |
-1.567x | -245.40% |
| 2015-06-30 | AU$4.33 Million ≈ $3.07 Million |
AU$-1.97 Million ≈ $-1.39 Million |
-0.454x | -9.20% |
| 2014-06-30 | AU$3.28 Million ≈ $2.32 Million |
AU$-1.36 Million ≈ $-965.08K |
-0.415x | -214.06% |
| 2013-06-30 | AU$4.88 Million ≈ $3.45 Million |
AU$1.78 Million ≈ $1.26 Million |
0.364x | +158.04% |
| 2012-06-30 | AU$1.88 Million ≈ $1.33 Million |
AU$-1.18 Million ≈ $-836.57K |
-0.627x | -0.39% |
| 2011-06-30 | AU$3.03 Million ≈ $2.15 Million |
AU$-1.90 Million ≈ $-1.34 Million |
-0.625x | +9.43% |
| 2010-06-30 | AU$3.74 Million ≈ $2.64 Million |
AU$-2.58 Million ≈ $-1.82 Million |
-0.690x | -402.75% |
| 2009-06-30 | AU$4.65 Million ≈ $3.29 Million |
AU$-637.56K ≈ $-451.11K |
-0.137x | +78.34% |
| 2008-06-30 | AU$5.96 Million ≈ $4.22 Million |
AU$-3.78 Million ≈ $-2.67 Million |
-0.634x | -32.50% |
| 2007-06-30 | AU$9.38 Million ≈ $6.64 Million |
AU$-4.49 Million ≈ $-3.18 Million |
-0.478x | -61.50% |
| 2006-06-30 | AU$14.41 Million ≈ $10.19 Million |
AU$-4.27 Million ≈ $-3.02 Million |
-0.296x | -126.85% |
| 2005-06-30 | AU$18.80 Million ≈ $13.30 Million |
AU$-2.45 Million ≈ $-1.74 Million |
-0.131x | -- |
About Cardiex Ltd
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more